Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
38
VRNS Quote, Financials, Valuation and Earnings
Last price:
$42.28
Seasonality move
:
0.44%
Day range:
$40.86 - $41.71
52-week range:
$39.11 - $60.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.41x
P/B ratio:
10.25x
Volume:
1.6M
Avg. volume:
1.9M
1-year change:
-15.54%
Market cap:
$4.7B
Revenue:
$551M
EPS (TTM):
-$0.86
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $292.7M | $390.1M | $473.6M | $499.2M | $551M | |
| Revenue Growth (YoY) | 15.15% | 33.29% | 21.4% | 5.39% | 10.38% | |
| Cost of Revenues | $44.3M | $59.4M | $69.8M | $71.8M | $93.8M | |
| Gross Profit | $248.4M | $330.7M | $403.8M | $427.4M | $457.1M | |
| Gross Profit Margin | 84.88% | 84.78% | 85.26% | 85.63% | 82.97% | |
| R&D Expenses | $99.4M | $137.9M | $177.9M | $183.8M | $196.8M | |
| Selling, General & Admin | $227.5M | $291.5M | $347.1M | $360.8M | $378M | |
| Other Inc / (Exp) | -$1.7M | -$1.7M | $5.5M | $10.3M | $11.9M | |
| Operating Expenses | $326.8M | $429.4M | $525M | $544.6M | $574.8M | |
| Operating Income | -$78.4M | -$98.7M | -$121.2M | -$117.2M | -$117.7M | |
| Net Interest Expenses | $5.8M | $10.4M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$85.9M | -$110.8M | -$110.8M | -$86.9M | -$83M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8.1M | $6M | $13.7M | $14M | $12.8M | |
| Net Income to Company | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
| Basic EPS (Cont. Ops) | -$1.00 | -$1.11 | -$1.14 | -$0.92 | -$0.86 | |
| Diluted EPS (Cont. Ops) | -$1.00 | -$1.11 | -$1.14 | -$0.92 | -$0.86 | |
| Weighted Average Basic Share | $94.3M | $105.3M | $109.3M | $109.1M | $111.7M | |
| Weighted Average Diluted Share | $94.3M | $105.3M | $109.3M | $109.1M | $111.7M | |
| EBITDA | -$69.6M | -$96.8M | -$95.5M | -$72M | -$67.3M | |
| EBIT | -$79.8M | -$107.7M | -$107.6M | -$83.7M | -$78.4M | |
| Revenue (Reported) | $292.7M | $390.1M | $473.6M | $499.2M | $551M | |
| Operating Income (Reported) | -$78.4M | -$98.7M | -$121.2M | -$117.2M | -$117.7M | |
| Operating Income (Adjusted) | -$79.8M | -$107.7M | -$107.6M | -$83.7M | -$78.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $95.2M | $126.6M | $142.6M | $154.1M | $158.5M | |
| Revenue Growth (YoY) | 31.2% | 32.96% | 12.67% | 8.05% | 2.87% | |
| Cost of Revenues | $12.5M | $17.4M | $17M | $19.3M | $26.1M | |
| Gross Profit | $82.7M | $109.2M | $125.6M | $134.8M | $132.5M | |
| Gross Profit Margin | 86.91% | 86.27% | 88.06% | 87.45% | 83.56% | |
| R&D Expenses | $27.9M | $40.1M | $45M | $48.1M | $50.5M | |
| Selling, General & Admin | $62M | $86.9M | $90.6M | $91.9M | $99.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $89.9M | $127M | $135.6M | $140M | $150M | |
| Operating Income | -$7.2M | -$17.8M | -$10M | -$5.2M | -$17.6M | |
| Net Interest Expenses | $2.8M | $2.4M | $1.2M | $4.8M | $4.3M | |
| EBT. Incl. Unusual Items | -$11.7M | -$21.9M | -$5.7M | $189K | -$9.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.3M | $3M | $5M | $1.1M | $3M | |
| Net Income to Company | -$19M | -$24.9M | -$10.7M | -$898K | -$13M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$19M | -$24.9M | -$10.7M | -$898K | -$13M | |
| Basic EPS (Cont. Ops) | -$0.20 | -$0.23 | -$0.10 | -$0.01 | -$0.12 | |
| Diluted EPS (Cont. Ops) | -$0.20 | -$0.23 | -$0.10 | -$0.01 | -$0.12 | |
| Weighted Average Basic Share | $95.3M | $107.4M | $109.2M | $109M | $112.5M | |
| Weighted Average Diluted Share | $95.3M | $107.4M | $109.2M | $109M | $112.5M | |
| EBITDA | -$5.7M | -$24.2M | $7.6M | $31.2M | $24.2M | |
| EBIT | -$8.6M | -$26.8M | $3.6M | $28.3M | $21.7M | |
| Revenue (Reported) | $95.2M | $126.6M | $142.6M | $154.1M | $158.5M | |
| Operating Income (Reported) | -$7.2M | -$17.8M | -$10M | -$5.2M | -$17.6M | |
| Operating Income (Adjusted) | -$8.6M | -$26.8M | $3.6M | $28.3M | $21.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $292.7M | $390.1M | $473.6M | $499.2M | $551M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.3M | $59.4M | $69.8M | $71.8M | $93.8M | |
| Gross Profit | $248.4M | $330.7M | $403.8M | $427.4M | $457.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $99.4M | $137.9M | $177.9M | $183.8M | $196.8M | |
| Selling, General & Admin | $227.5M | $291.5M | $347.1M | $360.8M | $378M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $326.8M | $429.4M | $525M | $544.6M | $574.8M | |
| Operating Income | -$78.4M | -$98.7M | -$121.2M | -$117.2M | -$117.7M | |
| Net Interest Expenses | $5.8M | $10.4M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$85.9M | -$110.8M | -$110.8M | -$86.9M | -$83M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8.1M | $6M | $13.7M | $14M | $12.8M | |
| Net Income to Company | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
| Basic EPS (Cont. Ops) | -$1.00 | -$1.12 | -$1.14 | -$0.92 | -$0.86 | |
| Diluted EPS (Cont. Ops) | -$1.00 | -$1.12 | -$1.14 | -$0.92 | -$0.86 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$69.6M | -$96.8M | -$95.5M | -$72M | -$67.3M | |
| EBIT | -$79.8M | -$107.7M | -$107.6M | -$83.7M | -$78.4M | |
| Revenue (Reported) | $292.7M | $390.1M | $473.6M | $499.2M | $551M | |
| Operating Income (Reported) | -$78.4M | -$98.7M | -$121.2M | -$117.2M | -$117.7M | |
| Operating Income (Adjusted) | -$79.8M | -$107.7M | -$107.6M | -$83.7M | -$78.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $390.1M | $473.6M | $499.2M | $551M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $59.4M | $69.8M | $71.8M | $93.8M | -- | |
| Gross Profit | $330.7M | $403.8M | $427.4M | $457.1M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $137.9M | $177.9M | $183.8M | $196.8M | -- | |
| Selling, General & Admin | $291.5M | $347.1M | $360.8M | $378M | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $429.4M | $525M | $544.6M | $574.8M | -- | |
| Operating Income | -$98.7M | -$121.2M | -$117.2M | -$117.7M | -- | |
| Net Interest Expenses | $10.4M | $1.2M | $4.8M | $4.3M | -- | |
| EBT. Incl. Unusual Items | -$110.8M | -$110.8M | -$86.9M | -$83M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6M | $13.7M | $14M | $12.8M | -- | |
| Net Income to Company | -$116.9M | -$124.5M | -$100.9M | -$95.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$116.9M | -$124.5M | -$100.9M | -$95.8M | -- | |
| Basic EPS (Cont. Ops) | -$1.12 | -$1.14 | -$0.92 | -$0.86 | -- | |
| Diluted EPS (Cont. Ops) | -$1.12 | -$1.14 | -$0.92 | -$0.86 | -- | |
| Weighted Average Basic Share | $421.1M | $437.1M | $436.6M | $446.6M | -- | |
| Weighted Average Diluted Share | $421.1M | $437.1M | $436.6M | $446.6M | -- | |
| EBITDA | -$96.8M | -$95.5M | -$72M | -$67.3M | -- | |
| EBIT | -$107.7M | -$107.6M | -$83.7M | -$78.4M | -- | |
| Revenue (Reported) | $390.1M | $473.6M | $499.2M | $551M | -- | |
| Operating Income (Reported) | -$98.7M | -$121.2M | -$117.2M | -$117.7M | -- | |
| Operating Income (Adjusted) | -$107.7M | -$107.6M | -$83.7M | -$78.4M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
| Short Term Investments | $64.2M | $1.9M | $364.7M | $303M | $382.8M | |
| Accounts Receivable, Net | $94.2M | $117.2M | $136M | $169.1M | $192.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $8.3M | $7.1M | $10.6M | $23.8M | $30.8M | |
| Other Current Assets | -- | -- | -- | -- | $116.8M | |
| Total Current Assets | $419.8M | $959.2M | $905.7M | $767.2M | $878.1M | |
| Property Plant And Equipment | $85.1M | $102M | $95.8M | $85.8M | $76.4M | |
| Long-Term Investments | -- | -- | -- | $211.1M | $658.9M | |
| Goodwill | $23.1M | $23.1M | $23.1M | $23.1M | $23.1M | |
| Other Intangibles | $5.8M | $4.3M | $2.8M | $1.3M | -- | |
| Other Long-Term Assets | $21.6M | $19.8M | $16.3M | $15.5M | $27.8M | |
| Total Assets | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
| Accounts Payable | $850K | $5.3M | $3M | $672K | $4.3M | |
| Accrued Expenses | $45.9M | $63.7M | $63.2M | $74.5M | $91.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $250.5M | |
| Current Portion Of Capital Lease Obligations | -- | $8.8M | $9.9M | $10M | $10.8M | |
| Other Current Liabilities | $37.3M | $29.8M | $42.2M | $40.5M | $62.8M | |
| Total Current Liabilities | $182.6M | $211.8M | $228.7M | $306.8M | $709.9M | |
| Long-Term Debt | $218.5M | $225.3M | $249M | $250.5M | $450.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $461.4M | $511.9M | $541.6M | $614.3M | $1.2B | |
| Common Stock | $95K | $108K | $108K | $109K | $113K | |
| Other Common Equity Adj | $9.4M | $6.1M | -$9.6M | -$8.6M | $2.7M | |
| Common Equity | $94.1M | $596.6M | $502.1M | $489.6M | $455.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $94.1M | $596.6M | $502.1M | $489.6M | $455.7M | |
| Total Liabilities and Equity | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
| Cash and Short Terms | $298.3M | $807.6M | $732.5M | $533.7M | $568.4M | |
| Total Debt | $218.5M | $225.3M | $249M | $250.5M | $700.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
| Short Term Investments | $64.2M | $1.9M | $364.7M | $303M | $382.8M | |
| Accounts Receivable, Net | $94.2M | $117.2M | $136M | $169.1M | $192.8M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $8.3M | $7.1M | $10.6M | $23.8M | $30.8M | |
| Other Current Assets | -- | -- | -- | -- | $116.8M | |
| Total Current Assets | $419.8M | $959.2M | $905.7M | $767.2M | $878.1M | |
| Property Plant And Equipment | $85.1M | $102M | $95.8M | $85.8M | $76.4M | |
| Long-Term Investments | -- | -- | -- | $211.1M | $658.9M | |
| Goodwill | $23.1M | $23.1M | $23.1M | $23.1M | $23.1M | |
| Other Intangibles | $5.8M | $4.3M | $2.8M | $1.3M | -- | |
| Other Long-Term Assets | $21.6M | $19.8M | $16.3M | $15.5M | $27.8M | |
| Total Assets | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
| Accounts Payable | $850K | $5.3M | $3M | $672K | $4.3M | |
| Accrued Expenses | $45.9M | $63.7M | $63.2M | $74.5M | $91.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $250.5M | |
| Current Portion Of Capital Lease Obligations | -- | $8.8M | $9.9M | $10M | $10.8M | |
| Other Current Liabilities | $37.3M | $29.8M | $42.2M | $40.5M | $62.8M | |
| Total Current Liabilities | $182.6M | $211.8M | $228.7M | $306.8M | $709.9M | |
| Long-Term Debt | $218.5M | $225.3M | $249M | $250.5M | $450.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $461.4M | $511.9M | $541.6M | $614.3M | $1.2B | |
| Common Stock | $95K | $108K | $108K | $109K | $113K | |
| Other Common Equity Adj | $9.4M | $6.1M | -$9.6M | -$8.6M | $2.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $94.1M | $596.6M | $502.1M | $489.6M | $455.7M | |
| Total Liabilities and Equity | $555.5M | $1.1B | $1B | $1.1B | $1.7B | |
| Cash and Short Terms | $298.3M | $807.6M | $732.5M | $533.7M | $568.4M | |
| Total Debt | $218.5M | $225.3M | $249M | $250.5M | $700.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
| Depreciation & Amoritzation | $10.2M | $10.9M | $12.2M | $11.7M | $11.1M | |
| Stock-Based Compensation | $68.6M | $109.8M | $142.9M | $139.8M | $126.7M | |
| Change in Accounts Receivable | -$19.1M | -$23M | -$18.8M | -$33.1M | -$23.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | $7.2M | $11.9M | $59.4M | $115.2M | |
| Capital Expenditures | $10.1M | $10.5M | $11.4M | $5.1M | $13.3M | |
| Cash Acquisitions | -$29.4M | -- | -- | -- | -- | |
| Cash From Investing | -$54.7M | $54.4M | -$374.3M | -$143.1M | -$532.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $245.3M | -- | -- | -- | $449.6M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$56.4M | -$43.5M | -- | |
| Other Financing Activities | -$29.3M | -$1M | -$31.1M | -$21.4M | -$93.8M | |
| Cash From Financing | $225.8M | $510.1M | -$75.6M | -$53.4M | $371.9M | |
| Beginning Cash (CF) | $68.9M | $234.1M | $805.8M | $367.8M | $230.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $165.2M | $571.7M | -$438M | -$137.1M | -$45.2M | |
| Ending Cash (CF) | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
| Levered Free Cash Flow | -$16M | -$3.3M | $475K | $54.3M | $101.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$19M | -$24.9M | -$10.7M | -$898K | -$13M | |
| Depreciation & Amoritzation | $2.8M | $2.6M | $4.1M | $3M | $2.6M | |
| Stock-Based Compensation | $19.4M | $38.1M | $34.8M | $31.6M | $32.6M | |
| Change in Accounts Receivable | -$34M | -$45.8M | -$44.3M | -$58M | -$73.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.7M | $338K | $3.4M | $10.4M | $24.3M | |
| Capital Expenditures | $3.1M | $6.4M | $3.8M | $2.2M | $4.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5.2M | $2.2M | -$332.3M | $110.4M | -$119.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -$464K | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$56.4M | -- | -- | |
| Other Financing Activities | -- | -- | -$1.6M | -$1.4M | -$1M | |
| Cash From Financing | $171K | $122K | -$57.6M | -$1.3M | -$1.5M | |
| Beginning Cash (CF) | $231.5M | $803.1M | $754.2M | $111.2M | $282.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6M | $2.6M | -$386.4M | $119.5M | -$96.6M | |
| Ending Cash (CF) | $234.1M | $805.8M | $367.8M | $230.7M | $185.6M | |
| Levered Free Cash Flow | $4.5M | -$6M | -$328K | $8.3M | $19.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$94M | -$116.9M | -$124.5M | -$100.9M | -$95.8M | |
| Depreciation & Amoritzation | $10.2M | $10.9M | $12.2M | $11.7M | $11.1M | |
| Stock-Based Compensation | $68.6M | $109.8M | $142.9M | $139.8M | $126.7M | |
| Change in Accounts Receivable | -$19.1M | -$23M | -$18.8M | -$33.1M | -$23.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.8M | $7.2M | $11.9M | $59.4M | $115.2M | |
| Capital Expenditures | $10.1M | $10.5M | $11.4M | $5.1M | $13.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$54.7M | $54.4M | -$374.3M | -$143.1M | -$532.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$56.4M | -$43.5M | -- | |
| Other Financing Activities | -- | -$1M | -$31.1M | -$21.4M | -$93.8M | |
| Cash From Financing | $225.8M | $510.1M | -$75.6M | -$53.4M | $371.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $165.2M | $571.7M | -$438M | -$137.1M | -$45.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$16M | -$3.3M | $475K | $54.3M | $101.9M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$116.9M | -$124.5M | -$100.9M | -$95.8M | -- | |
| Depreciation & Amoritzation | $10.9M | $12.2M | $11.7M | $11.1M | -- | |
| Stock-Based Compensation | $109.8M | $142.9M | $139.8M | $126.7M | -- | |
| Change in Accounts Receivable | -$23M | -$18.8M | -$33.1M | -$23.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.2M | $11.9M | $59.4M | $115.2M | -- | |
| Capital Expenditures | $10.5M | $11.4M | $5.1M | $13.3M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $54.4M | -$374.3M | -$143.1M | -$532.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $449.6M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$56.4M | -$43.5M | -- | -- | |
| Other Financing Activities | -$1M | -$31.1M | -$21.4M | -$93.8M | -- | |
| Cash From Financing | $510.1M | -$75.6M | -$53.4M | $371.9M | -- | |
| Beginning Cash (CF) | $2.6B | $3.1B | $1.1B | $815.4M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $571.7M | -$438M | -$137.1M | -$45.2M | -- | |
| Ending Cash (CF) | $3.1B | $2.7B | $989.7M | $770.3M | -- | |
| Levered Free Cash Flow | -$3.3M | $475K | $54.3M | $101.9M | -- | |
Get VRNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VRNS
Sector
P/E ratio
--
23.14x
PEG ratio
--
0.03x
P/B ratio
10.25x
2.24x
Price / LTM sales
8.41x
1.58x
Growth Metrics
VRNS
Sector
Revenue growth
2.87%
5.11%
Earnings growth
--
12.51%
Revenue (5-year growth)
16.73%
6.79%
Earnings forecast
$0.14
$0.14
Profitability
VRNS
Sector
Profitability FY 2024
$457.1M
$96.1M
Return on invested capital
-10.79%
1.26%
Return on assets
-7.44%
0.31%
Return on equity
-20.96%
2.11%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
May
6
Estimated Next Earnings Date
May
6
Balance Sheet
VRNS
Sector
Total cash
$568.4M
$56.5M
Short term investments
$382.8M
$21.4M
Total assets
$1.7B
$270.2M
Long term debt
$700.8M
$7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
